John H. Tucker
2018
In 2018, John H. Tucker earned a total compensation of $1.5M as President and Chief Executive Officer at scPharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $99,086 |
---|---|
Option Awards | $887,260 |
Salary | $494,227 |
Other | $10,734 |
Total | $1,491,307 |
Tucker received $887.3K in option awards, accounting for 59% of the total pay in 2018.
Tucker also received $99.1K in non-equity incentive plan, $494.2K in salary and $10.7K in other compensation.
Rankings
In 2018, John H. Tucker's compensation ranked 7,193rd out of 14,244 executives tracked by ExecPay. In other words, Tucker earned more than 49.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,193 out of 14,244 | 50th |
Division Manufacturing | 2,779 out of 5,765 | 52nd |
Major group Chemicals And Allied Products | 1,046 out of 2,128 | 51st |
Industry group Drugs | 883 out of 1,817 | 51st |
Industry Pharmaceutical Preparations | 690 out of 1,391 | 50th |
Source: SEC filing on April 30, 2019.
Tucker's colleagues
We found two more compensation records of executives who worked with John H. Tucker at scPharmaceuticals in 2018.
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019